Bloomberg on MSN10d
Alzheimer’s drugs eyed as next big obesity-like opportunityInvestors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
A rooftop deck at Variant Bio’s Seattle offices have a view of the city’s landmark Space Needle. (Cory Parris Photo) Variant Bio today announced a partnership with Novo Nordisk for disease ...
On Tuesday, his company, Variant Bio, based in Seattle, announced a $50 million collaboration with the drugmaker Novo Nordisk to develop drugs for metabolic disorders, including diabetes and ...
Variant Bio today announced a partnership with Novo Nordisk for disease research and development that could total $50 million for the biotech startup. The Seattle company is working with ...
Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...
From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024 ...
Shares were mixed in thin Asian trading on Monday after U.S. stocks edged back from their all-time high. Oil prices fell and ...
That’s when Chomko helped Campos apply to Ozempic maker Novo Nordisk’s patient assistance ... and volunteers for the Humane Society in Seattle. She also marvels that her trusted adviser ...
The Associated Press on MSN15d
Newsom committed California to making its own insulin. It’s at least a year behind his scheduleCalifornia is not one of those states. Newsom in October rejected a $35 monthly insulin copay cap. In his veto message, he cited the state’s $100 million investment in insulin production as an example ...
IMMvention Therapeutix to collaborate with Novo Nordisk on oral therapies for sickle cell ... innovation while working with an equity-backed biopharma start-up in Seattle soon after obtaining his MBA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback